Advertisement
Advertisement
PMN
ProMIS Neurosciences Inc. Common Shares (ON)
4.14
USDSponsored
+0.49
+13.53%
Nov 06, 11:18 UTC -5
Open
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) Earnings
PMN Earnings Reports
Positive Surprise Ratio
PMN beat 8 of 12 last estimates.
67%
Next Report
Next Week
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$1.29
Implied change from Q2 26 (Revenue/ EPS)
--
/+0.78%
Implied change from Q3 25 (Revenue/ EPS)
--
/-78.50%
ProMIS Neurosciences Inc. Common Shares (ON) earnings per share and revenue
On Aug 13, 2026, PMN reported earnings of -1.28 USD per share (EPS) for Q2 26, beating the estimate of -1.39 USD, resulting in a 8.07% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.47% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -1.29 USD, with revenue projected to reach -- USD, implying an increase of 0.78% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
INmune Bio Inc. Common stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.17
Surprise
-13.64%
Elutia Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+8.50%
Moderna, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$1.27
Actual
$0.38
Surprise
+129.79%
Genmab A/S ADS
Report Date
Nov 05, 2026 For Q3 26
Estimate
$3.86
Actual
$5.64
Surprise
+46.11%
Celcuity Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.46
Actual
-$1.33
Surprise
+9.05%
ANI Pharmaceuticals, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.22
Actual
$2.70
Surprise
+21.37%
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.31
Actual
$1.06
Surprise
+232.50%
LB Pharmaceuticals Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.65
Actual
-$1.79
Surprise
-8.27%
Allogene Therapeutics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.15
Actual
-$0.15
Surprise
+0.33%
Tectonic Therapeutic, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.35
Actual
-$1.08
Surprise
+20.37%
FAQ
What were ProMIS Neurosciences Inc. Common Shares (ON)'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, ProMIS Neurosciences Inc. Common Shares (ON) reported EPS of -$1.28, beating estimates by 8.07%, and revenue of $0.00, 0% as expectations.
How did the market react to ProMIS Neurosciences Inc. Common Shares (ON)'s Q2 2026 earnings?
The stock price moved up 0.47%, changed from $14.79 before the earnings release to $14.86 the day after.
When is ProMIS Neurosciences Inc. Common Shares (ON) expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for ProMIS Neurosciences Inc. Common Shares (ON)'s next earnings report?
Based on 3
analysts, ProMIS Neurosciences Inc. Common Shares (ON) is expected to report EPS of -$1.29 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.